Friday, October 08, 2004 5:32:27 PM
BOCA RATON, Fla.--(BUSINESS WIRE)--Oct. 7, 2004--DirectView Inc. (OTCBB:DRVW) announced today that Langley Park Investment Trust Plc was admitted to the Full List of the London Stock Exchange and that dealings in Langley shares have commenced on Oct. 7, 2004. DirectView, Inc. had previously signed an agreement with Langley to engage in a transaction for the funding of the company. The agreement calls for the purchase, by Langley, of DirectView Inc. restricted common shares, valued at the time of the closing at $2,398,750.00 USD, in exchange for shares of the investment company.
Langley has been established specifically to invest in U.S. micro cap companies with long-term growth potential.
Langley has entered into a "lock-up" agreement with DirectView Inc. pursuant to which it has agreed not to trade DirectView Inc. shares it will receive as a result of this transaction for a period of two years from the closing date. In full payment for the shares of DirectView Inc., Langley has issued to DirectView Inc. $2,398,750.00 USD equivalent of its shares at a price per share valued at One Pound Sterling.
Fifty percent of Langley's shares issued to DirectView Inc. will be held in escrow for two years following their issuance and in the event the per share market price of DirectView Inc. common stock at such time is less than the per share value of DirectView Inc. stock at the time of the closing, Langley shall be entitled to the return out of escrow a percentage of the investment company's shares equal to the market value of such decline. The remaining shares held in escrow shall be released to DirectView Inc. at the time of any such release back to Langley.
Jeffrey Robbins, President of DirectView stated, "We are very pleased to be receiving this capital infusion. This will enable DirectView to aggressively begin new marketing of our current products and services. It will further provide for continued development of our proprietary videoconferencing products."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM